BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    Recce Pharmaceuticals ASX RCE potential treatment COVID-19 CSIRO

    Recce Pharmaceuticals’ formulations to be evaluated as potential treatment for COVID-19

    Incannex Healthcare ASX IHL The Alfred Hospital CBD drug patients obstructive sleep apnoea

    Incannex partners with The Alfred Hospital for first phase 2b clinical trial to study impact of cannabinoid drug on patients with obstructive sl...

    Althea ASX AGH online sales medicinal cannabis products concierge

    Althea begins online medicinal cannabis sales supported by telemedicine

    Biotron ASX BIT HIV immune system evasion BIT225 AIDS

    Biotron’s BIT225 drug show to enhance body’s immune response to HIV

    Nyrada cholesterol-lowering Drug study results ASX NYR PCSK9 inhibitor

    Nyrada reveals encouraging cholesterol-lowering drug study results

    Neurotech ASX NTI cannabis treat autism epilepsy ADHD Dolce Cann strain

    Neurotech to treat autism, epilepsy and ADHD using Dolce Cann’s proprietary cannabis strains

    MGC Pharmaceuticals ASX MXC Mahatma Gandhi Mission’s Medical College & Hospital Aurangabad India World Health Organisation WHO

    MGC Pharma expands ArtemiC Phase II trial to include COVID-19 patients in India

    Incannex Healthcare ASX IHL record sales cannabis oil CBD Cannagesia

    Incannex Healthcare shifts from making an impression to setting sales records

    Osteopore distribution agreement Bioplate ASX OSX 3D printed bioresorbable products United States

    Osteopore signs first US distribution deal for 3D-printed craniofacial scaffolds

    Alterity Therapeutics ASX ATH Parkinsons orphan drug FDA

    FDA provides development pathway for Alterity Therapeutics’ drug to treat multiple system atrophy

    Telix Pharmaceuticals ASX TLX FDA Breakthrough Therapy Designation Renal Cancer imaging product

    FDA grants Telix breakthrough therapy designation for renal cancer imaging product

    Aroa Biosurgery IPO ASX Endoform ARX Brian Ward

    Aroa Biosurgery plans ASX listing to corner complex wound healing market

    Althea MyAccess Clinics UK expansion Drug Science ASX AGH

    Althea’s MyAccess Clinics boosts UK expansion, teams up with Drug Science

    PharmAust ASX PAA cancer drug monepantel COVID-19

    Repeat experiment proves PharmAust’s lead cancer drug can reduce infectivity of COVID-19 cells

    Race Oncology ASX RAC Acute Myeloid Leukaemia bisantrene Phase 2 clinical trial

    Race Oncology confirms positive results from Bisantrene drug trial on patients with advanced acute myeloid leukaemia

    Cann Global ASX CGB clinical trials unique cannabis strain help slow progression multiple sclerosis medical research group

    Cann Global’s clinical trials show unique cannabis strain can help slow progression of multiple sclerosis

    Integral Diagnostics ASX IDX Ascot Radiology acquisition

    Integral Diagnostics to expand NZ footprint with acquisition of Ascot Radiology

    Immuron ASX IMC NASDAQ IMRN US DoD Naval Medical Research Center Phase 2 FDA Prevent Acute Infectious Diarrhea

    Immuron and US Naval Medical Research Center prepare to develop novel oral therapeutic for E-Coli

    Atomo Diagnostics ASX AT1 COVID-19 NG Biotech blood antibody IgG:IgM AtomoRapid

    Atomo Diagnostics secures exclusive rights to market COVID-19 antibody test

    PharmAust ASX PAA study lead cancer drug could suppress COVID-19 infectivity SARS-CoV-2

    Studies show PharmAust’s lead cancer drug could suppress COVID-19 infectivity

    Dimerix ASX DXB REMAP-CAP lead drug candidate Acute Respiratory Distress Syndrome ARDS COVID-19

    Dimerix’s lead drug candidate to be included in key clinical study for COVID-19 respiratory patients

    Load more
    Small Caps ASX Australian stock market
    Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2020 Small Caps. All rights reserved.